These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 26996422)

  • 1. In Vivo Models for Incretin Research: From the Intestine to the Whole Body.
    Oh TJ
    Endocrinol Metab (Seoul); 2016 Mar; 31(1):45-51. PubMed ID: 26996422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.
    Muscelli E; Mari A; Natali A; Astiarraga BD; Camastra S; Frascerra S; Holst JJ; Ferrannini E
    Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1144-50. PubMed ID: 16478775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour necrosis factor-alpha infusion produced insulin resistance but no change in the incretin effect in healthy volunteers.
    Nielsen ST; Lehrskov-Schmidt L; Krogh-Madsen R; Solomon TP; Lehrskov-Schmidt L; Holst JJ; Møller K
    Diabetes Metab Res Rev; 2013 Nov; 29(8):655-63. PubMed ID: 23904405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recovery of the incretin effect in type 2 diabetic patients after biliopancreatic diversion.
    Novaes FS; Vasques AC; Pareja JC; Knop FK; Tura A; Chaim ÉA; Geloneze B
    J Clin Endocrinol Metab; 2015 May; 100(5):1984-8. PubMed ID: 25742514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and "isoglycemic" intravenous glucose.
    Vardarli I; Arndt E; Deacon CF; Holst JJ; Nauck MA
    Diabetes; 2014 Feb; 63(2):663-74. PubMed ID: 24186866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin hormones and beta cell function in chronic pancreatitis.
    Knop FK
    Dan Med Bull; 2010 Jul; 57(7):B4163. PubMed ID: 20591345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incretin effect in critically ill patients: a case-control study.
    Nielsen ST; Janum S; Krogh-Madsen R; Solomon TP; Møller K
    Crit Care; 2015 Nov; 19():402. PubMed ID: 26567860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
    Mingrone G
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unraveling the science of incretin biology.
    Nauck MA
    Eur J Intern Med; 2009 Jul; 20 Suppl 2():S303-8. PubMed ID: 19580949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the science of incretin biology.
    Nauck MA
    Am J Med; 2009 Jun; 122(6 Suppl):S3-S10. PubMed ID: 19464426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced glucose tolerance and insulin resistance induced by steroid treatment, relative physical inactivity, and high-calorie diet impairs the incretin effect in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2010 Jul; 95(7):3309-17. PubMed ID: 20410219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incretin physiology and pathophysiology from an Asian perspective.
    Cho YM
    J Diabetes Investig; 2015 Sep; 6(5):495-507. PubMed ID: 26417406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The incretin system and its role in type 2 diabetes mellitus.
    Holst JJ; Vilsbøll T; Deacon CF
    Mol Cell Endocrinol; 2009 Jan; 297(1-2):127-36. PubMed ID: 18786605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice.
    Moriya R; Shirakura T; Ito J; Mashiko S; Seo T
    Am J Physiol Endocrinol Metab; 2009 Dec; 297(6):E1358-65. PubMed ID: 19808907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wnt and incretin connections.
    García-Jiménez C
    Vitam Horm; 2010; 84():355-87. PubMed ID: 21094908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP.
    Theodorakis MJ; Carlson O; Michopoulos S; Doyle ME; Juhaszova M; Petraki K; Egan JM
    Am J Physiol Endocrinol Metab; 2006 Mar; 290(3):E550-9. PubMed ID: 16219666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incretin effect does not differ in trained and untrained, young, healthy men.
    Lund MT; Dalby S; Hartmann B; Helge J; Holst JJ; Dela F
    Acta Physiol (Oxf); 2014 Mar; 210(3):565-72. PubMed ID: 24354574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physiology of incretins and loss of incretin effect in type 2 diabetes and obesity.
    Opinto G; Natalicchio A; Marchetti P
    Arch Physiol Biochem; 2013 Oct; 119(4):170-8. PubMed ID: 23859800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal factors contribute to glucometabolic disturbances in nondiabetic patients with end-stage renal disease.
    Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
    Kidney Int; 2013 May; 83(5):915-23. PubMed ID: 23325073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.